Share on StockTwits

Bodycote PLC (LON:BOY)‘s stock had its “outperform” rating reiterated by stock analysts at Credit Suisse in a report issued on Tuesday. They currently have a GBX 810 ($13.89) price objective on the stock. Credit Suisse’s price target indicates a potential upside of 13.05% from the company’s current price.

BOY has been the subject of a number of other recent research reports. Analysts at Panmure Gordon reiterated a “buy” rating on shares of Bodycote PLC in a research note on Monday, June 2nd. They now have a GBX 877 ($15.04) price target on the stock. Separately, analysts at Numis Securities Ltd reiterated an “add” rating on shares of Bodycote PLC in a research note on Thursday, May 29th. They now have a GBX 825 ($14.15) price target on the stock. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Bodycote PLC in a research note on Monday, May 12th. They now have a GBX 895 ($15.35) price target on the stock. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and seven have issued a buy rating to the company’s stock. Bodycote PLC currently has an average rating of “Hold” and a consensus price target of GBX 804.64 ($13.80).

Shares of Bodycote PLC (LON:BOY) opened at 711.50 on Tuesday. Bodycote PLC has a 52 week low of GBX 533.00 and a 52 week high of GBX 832.00. The stock’s 50-day moving average is GBX 718.5 and its 200-day moving average is GBX 725.. The company’s market cap is £1.348 billion.

Bodycote plc (LON:BOY) is a specialized plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.